Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke

This study has been completed.

Sponsor:

Collaborator:

Zhejiang Otsuka Pharmaceutical Co., Ltd.

Information provided by:

Otsuka Beijing Research Institute

ClinicalTrials.gov Identifier:

NCT00202020

First received: September 12, 2005

Last updated: March 15, 2006

Last verified: March 2006

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2006
Estimated Primary Completion Date:	No date given

No publications provided by Otsuka Beijing Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, Cheng Y, Ding M, Li Y, Hong Z, Wu J, Zeng J, Yao C, Huang Y; CASISP Study Group. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke. 2012 Nov;43(11):2916-22. doi: 10.1161/STROKEAHA.112.658369. Epub 2012 Sep 4.

To Top